Publication | Closed Access

Polymer–lipid hybrid nanoparticles synchronize pharmacokinetics of co-encapsulated doxorubicin–mitomycin C and enable their spatiotemporal co-delivery and local bioavailability in breast tumor

NanoparticlesNanomedicineEngineeringPolymer–lipid Hybrid NanoparticlesMedicinePolymer-drug ConjugateTherapeutic NanomaterialsLocal BioavailabilityDrug Delivery SystemsNano-drug DeliveryBiomedical EngineeringDrug Delivery SystemPharmacologyCo-encapsulated Doxorubicin–mitomycin C